Ardent Health (ARDT) risk factors, FY2024 10-K

Risks Related to Our Business and Industry

1. 01Changes in government healthcare programs, including Medicare and Medicaid, could have an adverse effect on our revenues and business
2. 02Our hospitals, outpatient centers and other healthcare businesses operate in competitive environments, and competition in our markets may adversely affect patient volumes and other aspects of our business
3. 03Our performance depends on our ability to recruit and retain quality physicians
4. 04Our financial performance could be adversely affected by competition for staffing, the shortage of experienced nurses and other healthcare professionals, labor union activity and factors related to our employment of physicians
5. 05Changes to physician utilization practices and treatment methodologies and other factors outside our control that impact demand for medical services may reduce our revenues and ability to grow profitably
6. 06Third party payor controls designed to reduce costs and other payor practices intended to decrease inpatient services, surgical procedure volumes or reimbursement for services rendered may reduce our revenues
7. 07Industry trends towards value-based purchasing and care coordination among healthcare providers may present us with operational, financial and competitive challenges
8. 08We depend on key personnel, and losing one or more of our senior management team or local management personnel could have a material adverse effect on our business
9. 09We may not be able to successfully complete acquisitions or strategic JVs on acceptable terms, which may slow our growth rate
10. 10We may fail to realize all of the anticipated benefits of our past and any future acquisitions, or those benefits may take longer to realize than expected. We may also encounter significant difficulties in integrating these acquired businesses into our operations
11. 11We may be subject to liabilities because of claims brought against our hospitals, physician practices, outpatient facilities or other business operations or against healthcare providers that provide services at our facilities
12. 12The failure to obtain our medical supplies and drugs at favorable prices or in sufficient volumes could cause our operating results to decline
13. 13We are subject to a variety of operational, legal and financial risks associated with outsourcing functions to third parties
14. 14Our facilities are heavily concentrated in Texas and Oklahoma, which makes us sensitive to regulatory, economic and competitive conditions and changes in those states
15. 15Economic factors have affected, and may continue to impact, our business, financial condition and results of operations
16. 16Our hospitals and other healthcare facilities may be negatively impacted by severe weather, climate change, and other factors beyond our control, which could restrict patient access to care or cause one or more of our facilities to close temporarily or permanently
17. 17We face certain risks related to the Ventas Master Lease, pursuant to which we lease ten of our hospitals and the associated Relative Rights Agreement
18. 18Our principal equity holders’ interests may conflict with yours
19. 19Our significant level of indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, and prevent us from meeting our obligations under our debt instruments
20. 20The agreements that govern our existing indebtedness impose significant operating and financial restrictions on us and our subsidiaries, which may prevent us from capitalizing on business opportunities
21. 21In addition, our ABL Facilities (as defined below) require us to maintain a minimum fixed charge coverage ratio if availability under our ABL Facilities falls below a certain threshold
22. 22Despite our current level of indebtedness, we may be able to incur substantially more debt and enter into other transactions which could further exacerbate the risks to our financial condition described above
23. 23A deterioration of public health conditions associated with a future pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate or that otherwise affects our facilities could adversely impact our business
24. 24The estimates of market opportunity and forecasts of market growth included in this report may prove to be inaccurate, and even if our addressable markets achieve the forecasted growth, our business could fail to grow at similar rates
25. 25Our cash and cash equivalents could be adversely affected if the financial institutions in which we hold our cash and cash equivalents fail

Risks Related to Regulation

1. 26If we fail to comply with extensive laws and government regulations, we could suffer penalties or be required to make significant changes to our operations
2. 27Among these laws are the Stark Law, federal Anti-Kickback Statute, the FCA, the federal Civil Monetary Penalties Law, EMTALA, EKRA, HIPAA, CLIA and similar state laws
3. 28broad discretion. Some state fraud and abuse laws apply to items or services reimbursed by any payor, including patients and commercial insurers, not just those reimbursed by a federally funded healthcare program
4. 29We may be the subject of government investigations, claims, audits, whistleblower and other litigation and payor audits
5. 30We are required to treat patients with emergency medical conditions regardless of ability to pay
6. 31Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations and financial condition
7. 32Our business may be adversely impacted by changes in public healthcare policy
8. 33There are significant legal and regulatory restrictions on our hospitals that have physician owners
9. 34Tax matters, including disagreements with taxing authorities and imposition of new taxes, could impact our results of operations and financial condition
10. 35We incur substantial costs as a result of operating as a public company and our management is required to devote substantial time to new compliance initiatives and corporate governance practices of which we have limited experience
11. 36If we fail to maintain proper and effective internal control over financial reporting, our ability to produce accurate and timely financial statements could be impaired and investors’ views of us could be harmed

Risks Related to Technology

1. 37Healthcare technology initiatives, particularly those related to sharing patient data and interoperability, may adversely affect our operations
2. 38If we do not continually enhance our hospitals with the most recent technological advances in diagnostic and surgical equipment or obtain reimbursement from third party payors for the cost of such new technologies, our business and results of operations may be adversely affected

Risks Related to Ownership of our Common Stock

1. 39Our stock price could be volatile, and, as a result, our stockholders may not be able to resell their shares at or above the price paid for them
2. 40If our operating and financial performance in any given period does not meet the guidance that we provide to the public, the price of our common stock may decline
3. 41We are a “controlled company” within the meaning of the rules of the NYSE and, as a result we rely on, exemptions from certain corporate governance requirements; you will not have the same protections afforded to stockholders of companies that are subject to all such requirements
4. 42Certain of our directors have relationships with our controlling stockholder, EGI-AM, and other affiliated entities of Equity Group Investments ("EGI"), which may cause conflicts of interest with respect to our business
5. 43Our certificate of incorporation contains a provision renouncing our interest and expectancy in certain corporate opportunities
6. 44Some provisions of Delaware law and our governing documents could discourage a takeover that stockholders may consider favorable
7. 45Future sales, or the perception of future sales, of our common stock may depress the price of our common stock
8. 46common stock could decline significantly. Moreover, the perception in the public market that we or our stockholders might sell shares of our common stock could depress the market price of those shares
9. 47If securities or industry analysts do not publish research or publish misleading or unfavorable research about our business, our share price and trading volume may decline
10. 48We could be subject to securities class action litigation
11. 49We do not intend to pay cash dividends for the foreseeable future